2012-10-15T12:40:22-05:00 2011-12-31 521853933 RIBIS JONES & MARESCA PA 10500 LITTLE PATUXENT PARKWAY SUITE COLUMBIA MD 21044 990 2011-01-01 522320756 ACCELERATE BRAIN CANCER CURE INC ACCE 2024193140 1717 RHODE ISLAND AVENUE NW NO 700 WASHINGTON DC 20036 MAX WALLACE 2024193140 2012-09-21 1 DAVID JONES P01361002 4108840220 2011 2016-02-24 21:20:13Z MAX WALLACE 1717 RHODE ISLAND AVENUE NW NO 700 WASHINGTON DC 20036 2058326 0 X WWW.ABC2.ORG X 2001 DC ACCELERATE BRAIN CANCER CURE HAS A SINGLE FOCUS-TO HASTEN THE DISCOVERY OF A CURE FOR BRAIN CANCER. 9 9 6 0 0 0 2000010 1871363 14879 0 750 693 0 0 2015639 1872056 840455 813600 0 0 581212 612506 0 0 313352 484578 553055 1906245 1979161 109394 -107105 2056845 2223478 487979 651086 1568866 1572392 THE PRIMARY OBJECTIVE OF ACCELERATE BRAIN CANCER CURE, INC. IS TO ACCELERATE PROGRESS IN WHAT HAS BEEN AN UNDERSERVED FIELD OF RESEARCH; THE ORGANIZATION AIMS TO RAISE AWARENESS ABOUT BRAIN CANCER AND HELP MOBILIZE CRITICAL SCIENTIFIC RESEARCH THROUGH RESEARCH GRANTS. 0 0 1403136 813600 110631 ACCELERATE BRAIN CANCER CURE, INC. (ABC2) BELIEVES A FOCUSED AND AGGRESSIVE ENTREPRENEURIAL MODEL WILL INCREASE THE NUMBER OF THERAPIES DISCOVERED AND ENABLE THOSE THERAPIES TO BE AVAILABLE TO DOCTORS AND PATIENTS MORE QUICKLY. ABC2 PROVIDES RESEARCHERS WITH THE PIVOTAL SUPPORT THEY NEED TO MAKE CRITICAL BREAKTHROUGHS. IT FUNDS TRANSLATIONAL RESEARCH AIMED AT FINDING THE FASTEST POSSIBLE ROUTE TO A CURE. ABC2 SUPPORTS A RANGE OF MEDICAL RESEARCH ORGANIZATIONS. 1403136 1 1 0 0 0 0 0 0 0 0 1 0 0 0 1 1 1 0 0 0 0 0 0 0 1 0 0 1 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 15 0 1 6 1 0 0 0 0 0 0 0 0 0 0 X 9 9 1 0 0 0 0 0 0 1 0 0 0 0 1 1 1 1 1 1 0 0 CA X THE ORGANIZATION 2024193140 1717 RHODE ISLAND AVENUE NW NO 700 WASHINGTON DC 20036 STACEY CASE 1.00 X 0 0 0 STEPHEN CASE 1.00 X 0 0 0 NANCY PFUND 1.00 X 0 0 0 DAVID GOLDEN 1.00 X 0 0 0 JEAN CASE 1.00 X 0 0 0 DOUG HOLLADAY 1.00 X 0 0 0 LARRY PROBST 1.00 X 0 0 0 JONATHAN WEINBERG 1.00 X 0 0 0 GARY WIMMER 1.00 X 0 0 0 MAX WALLACE 40.00 X 247690 0 10263 247690 0 10263 1 0 1 0 0 1211305 660058 1871363 693 693 186270 1211305 186270 0 1872056 0 0 693 813600 813600 247690 79515 76130 92045 290639 93302 89332 108005 6573 6573 34766 9377 6817 18572 32838 10379 9612 12847 50318 50318 204837 155729 16483 32625 39060 13215 1206 24639 28099 8289 3079 16731 16201 6525 4838 4838 34230 32214 67 1949 149265 149265 2766 2766 15087 13129 1888 70 MEALS AND ENTERTAINMENT 13192 12024 137 1031 1979161 1403136 262673 313352 1864983 2093174 158006 112231 14055 9638 22473 15812 9414 6661 13 10374 1774 2056845 2223478 15134 42186 472295 608600 550 300 487979 651086 X 1410860 1460161 158006 112231 1568866 1572392 2056845 2223478 X -107105 110631 X X 0 1 1 X 0 X 1662487 1700167 1403218 2220324 2057633 9043829 1662487 1700167 1403218 2220324 2057633 9043829 520388 8523441 169824 66472 3621 750 693 241360 9285189 2602 0.91800 0.77130 X RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED 22473 15812 6661 6661 DUE TO AFFILIATES 300 300 1872056 1979161 -107105 110631 110631 3526 2190744 132418 186270 318688 1872056 0 1872056 2187218 132418 186270 318688 1868530 110631 110631 1979161 DESCRIPTION OF UNCERTAIN TAX POSITIONS UNDER FIN 48: PART X: ABC2 IS RECOGNIZED AS A 501(C)(3) ORGANIZATION, EXEMPT FROM FEDERAL INCOME TAX ON INCOME OTHER THAN UNRELATED BUSINESS INCOME UNDER SECTION 501(A) OF THE INTERNAL REVENUE CODE. ABC2 HAS BEEN RECOGNIZED BY THE INTERNAL REVENUE SERVICE AS AN ORGANIZATION THAT IS A PUBLIC CHARITY AND NOT A PRIVATE FOUNDATION. ABC2 RECOGNIZES THE EFFECT OF INCOME TAX POSITIONS ONLY IF THOSE POSITIONS ARE MORE LIKELY THAN NOT TO BEING SUSTAINED. ABC2 DOES NOT BELIEVE ITS FINANCIAL STATEMENT INCLUDE ANY UNCERTAIN TAX POSITIONS. THERE WERE NO TAX LIABILITIES RECORDED FOR THE YEARS ENDED DECEMBER 31, 2011 AND 2010. ABC2'S INCOME TAX RETURNS ARE SUBJECT TO EXAMINATION BY THE INTERNAL REVENUE SERVICE FOR A PERIOD OF THREE YEARS FROM THE DATE THEY WERE FILED, EXCEPT UNDER CERTAIN CIRCUMSTANCES. ABC2'S FORM 990 TAX RETURNS FOR THE YEARS 2008 THROUGH 2010 ARE OPEN FOR A TAX EXAMINATION BY THE INTERNAL REVENUE SERVICE, ALTHOUGH NO REQUEST HAS BEEN MADE AS OF THE DATE OF THESE FINANCIAL STATEMENTS. PART XI, LINE 8 - OTHER ADJUSTMENTS: REVERSAL OF GRANT EXPENSES 110,631. PART XII, LINE 2D - OTHER ADJUSTMENTS: DIRECT FUNDRAISING EXPENSES 186,270. PART XIII, LINE 2D - OTHER ADJUSTMENTS: FUNDRAISING EXPENSES 186,270. PART XIII, LINE 4B - OTHER ADJUSTMENTS: REVERSAL OF GRANT EXPENSES 110,631. RACE FOR HOPE FUNDRAISING EVENT-DC 1179987 1059235 120752 3113 16368 101271 CITY SPECIFIC WALKS 217588 152070 65518 550 5735 59233 1 1397575 1211305 186270 3663 22103 160504 186270 0 1 MILES FOR HOPE 1684 BELCHER ROAD CLEARWATER FL 337651313 956006143 501(C)(3) 30000 OPTIMIZING DENDRITIC CELL VACCINATION FOR LOW-GRADE GLIOMA PATIENTS. FLORIDA CENTER FOR BRAIN TUMOR RESEARCH UNIVERSITY OF FLORIDA PO BOX 100265 GAINESVILLE FL 32610 596002052 501(C)(3) 50000 A GRANT TO SUPPORT FLORIDA RESEARCH EFFORTS INCLUDING: THE INTERPLAY BETWEEN EGFRVIII AND C-MET IN GLIOBLASTOMA MULTIFORME, TARGETING THE CHEMOKINE RECEPTORS IN GLIOBLASTOMA, IMPROVING GLIOMA TREATMENT WITH ADAPTIVE THERAPY, AND THE USE OF NIFURTIMOX AND RADIATION FOR MEDULLOBLASTOMA THERAPY. THE V FOUNDATION FOR CANCER RESEARCH 106 TOWERVIEW COURT CARY NC 27513 133705951 501(C)(3) 500000 DEVELOPING NOVEL APPROACHES TO TARGET GLIOMA REGULUS THERAPEUTICS INC 3545 JOHN HOPKINS COURT 210 SAN DIEGO CA 92121 N/A 150000 THE DISCOVERY AND DEVELOPMENT OF NOVEL THERAPEUTICS, TARGETING DYSREGULATED MICRORNA'S IN GBM. OREGON HEALTH AND SCIENCE UNIVERSITY 3181 SW SAM JACKSON PARK ROAD PORTLAND OR 97239 931176109 GOVERNMENTAL UNIT 83600 RAPID PRECLINICAL DEVELOPMENT OF A TARGETED THERAPY COMBINATION FOR DIPG 4 1 PROCEDURE FOR MONITORING GRANTS IN THE U.S.: PART I, LINE 2: SCHEDULE I, PART I, LINE 2: ABC2 CLOSELY MONITORS THE PROGRESS OF THE RESEARCHERS IT FUNDS THROUGH ITS GRANT PROGRAM. THE ORGANIZATION REQUIRES SCIENTIFIC PROGRESS REPORTS AND COMPLETE FINANCIAL ACCOUNTING OF EXPENDITURES BEFORE RELEASING ADDITIONAL FUNDS AS WELL AS FINAL GRANT REPORTS INCLUDING FINANCIAL REPORTS. IN ADDITION, ABC2 HOLDS AN ANNUAL SCIENTIFIC MEETING AT WHICH TIME CERTAIN GRANTEES PRESENT THEIR PROGRESS. X X X 0 0 0 0 0 0 0 0 0 MAX WALLACE 247690 0 0 0 0 0 0 0 10263 0 257953 0 0 0 FORM 990, PART VI, SECTION A, LINE 2 STEPHEN CASE, CHAIRMAN & BOARD MEMBER AND JEAN CASE, BOARD MEMBER ARE CO-FOUNDERS AND SPOUSES. STACEY CASE, BOARD MEMBER AND CO-FOUNDER, IS THE SISTER-IN-LAW OF STEPHEN CASE. THESE BOARD MEMBERS ALSO HAVE BUSINESS RELATIONSHIPS. FORM 990, PART VI, SECTION A, LINE 8B ABC2 HAS NO COMMITTEES - ONLY A GOVERNING BODY, THE BOARD OF DIRECTORS. FORM 990, PART VI, SECTION B, LINE 11 MAX WALLACE, THE CHIEF EXECUTIVE OFFICER OF ACCELERATE BRAIN CANCER CURE, INC. REVIEWS AND SIGNS THE 990 BEFORE IT IS FILED. FORM 990, PART VI, SECTION B, LINE 12C THE BOARD OF DIRECTORS REVIEWS THE CONFLICT OF INTEREST POLICY AT ITS ANNUAL BOARD MEETING. INDEPENDENCE IS ALSO CONFIRMED PRIOR TO THE AWARDING OF ANY EXPENDITURE RESPONSIBILITY GRANT. FORM 990, PART VI, SECTION B, LINE 15A THE CHIEF EXECUTIVE OFFICER JOINED THE ORGANIZATION IN 2008. AS PART OF THE EXECUTIVE SEARCH PROCESS AN INDEPENDENT SEARCH FIRM PERFORMED AN INDUSTRY COMPENSATION ANALYSIS. THE LAST COMPENSATION REVIEW TOOK PLACE IN THE FALL OF 2010 AND UTILIZED AN INDEPENDENT COMPENSATION CONSULTANT, COPIES OF SIMILAR SIZE ORGANIZATIONS' FORMS 990 AND A COMPENSATION STUDY. THE ORGANIZATION HAD NO KEY EMPLOYEES. FORM 990, PART VI, SECTION C, LINE 19 THE ORGANIZATION MAKES ITS GOVERNING DOCUMENTS, CONFLICT OF INTEREST POLICY, AND FINANICAL STATEMENTS AVAILABLE FOR PUBLIC INSPECTION UPON REQUEST. CHANGES IN NET ASSETS OR FUND BALANCES: FORM 990, PART XI, LINE 5: REVERSAL OF GRANT EXPENSES 110,631. TOTAL TO FORM 990, PART XI, LINE 5: 110,631. FORM 990, PART XII, LINE 2C THERE HAS BEEN NO CHANGE IN THIS PROCESS SINCE THE LAST YEAR.